Michael M. Segal, M.D. Ph.D.

Neurogenetics, channelopathies, epilepsy, microisland cultures
"Michael Segal"
Mean distance: 12.29 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Segal MM, Abdellateef M, El-Hattab AW, et al. (2015) Clinical pertinence metric enables hypothesis-independent genome-phenome analysis for neurologic diagnosis. Journal of Child Neurology. 30: 881-8
Segal MM. (2014) We cannot say whether attention deficit hyperactivity disorder exists, but we can find its molecular mechanisms. Pediatric Neurology. 51: 15-6
Segal MM, Williams MS, Gropman AL, et al. (2014) Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workup. Journal of Child Neurology. 29: 487-92
Segal MM, Schiffmann R. (2012) Decision support for diagnosis: co-evolution of tools and resources. Neurology. 78: 1546-7
Segal MM, Rogers GF, Needleman HL, et al. (2007) Hypokalemic sensory overstimulation. Journal of Child Neurology. 22: 1408-10
Segal MM. (2006) Mobile medical computing driven by the complexity of neurologic diagnosis. Journal of Child Neurology. 21: 595-9
Segal MM. (2005) Computational approaches to epilepsy diagnosis: Exchanging cases and classifying diagnoses Epileptic Disorders. 7: 154-155
Rosenberg PA, Dai W, Gan XD, et al. (2003) Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. Journal of Neuroscience Research. 71: 237-45
Segal MM. (2002) Sodium channels and epilepsy electrophysiology. Novartis Foundation Symposium. 241: 173-80; discussion 1
Chen HS, Wang YF, Rayudu PV, et al. (1998) Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience. 86: 1121-32
See more...